541 related articles for article (PubMed ID: 9215638)
1. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
Hayashi H; Abdollah S; Qiu Y; Cai J; Xu YY; Grinnell BW; Richardson MA; Topper JN; Gimbrone MA; Wrana JL; Falb D
Cell; 1997 Jun; 89(7):1165-73. PubMed ID: 9215638
[TBL] [Abstract][Full Text] [Related]
2. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
3. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
4. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
6. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.
Macías-Silva M; Abdollah S; Hoodless PA; Pirone R; Attisano L; Wrana JL
Cell; 1996 Dec; 87(7):1215-24. PubMed ID: 8980228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
[TBL] [Abstract][Full Text] [Related]
8. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
9. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.
Nakao A; Afrakhte M; Morén A; Nakayama T; Christian JL; Heuchel R; Itoh S; Kawabata M; Heldin NE; Heldin CH; ten Dijke P
Nature; 1997 Oct; 389(6651):631-5. PubMed ID: 9335507
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells.
Dooley S; Delvoux B; Streckert M; Bonzel L; Stopa M; ten Dijke P; Gressner AM
FEBS Lett; 2001 Jul; 502(1-2):4-10. PubMed ID: 11478938
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
13. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
14. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2.
Hayes S; Chawla A; Corvera S
J Cell Biol; 2002 Sep; 158(7):1239-49. PubMed ID: 12356868
[TBL] [Abstract][Full Text] [Related]
15. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
18. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.
Hocevar BA; Smine A; Xu XX; Howe PH
EMBO J; 2001 Jun; 20(11):2789-801. PubMed ID: 11387212
[TBL] [Abstract][Full Text] [Related]
19. The role of TGFbeta in human cancers.
Wong SF; Lai LC
Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
